Are all MRSA made equal?

Area of Science:

• Infectious Diseases
• Microbiology
• Clinical Medicine

Background:

• Methicillin-resistant Staphylococcus aureus (MRSA) presents a significant health and economic burden.
• While methicillin-susceptible S. aureus (MSSA) exhibits heterogeneity in disease causation, this is less documented for MRSA.
• MRSA is suggested to be at least as pathogenic as MSSA based on animal and human studies.

Purpose of the Study:

• To review and critically assess comparative virulence studies of MRSA and MSSA.
• To highlight limitations in existing comparative studies, particularly regarding MRSA clonality.
• To propose future research directions for robust MRSA-MSSA virulence comparisons.

Main Methods:

• Review of retrospective clinical studies comparing MRSA and MSSA virulence.
• Analysis of data from animal models and human studies.
• Consideration of the impact of isolate clonality on comparative findings.

Main Results:

• A trend suggests MRSA is a more aggressive pathogen than MSSA.
• Many comparative studies are limited by clinical design flaws.
• Few studies have established clonality among MRSA isolates, potentially biasing results.

Conclusions:

• MRSA may be more virulent, but this needs further investigation.
• Hypervirulent MRSA clones could bias existing comparative studies.
• Future research requires prospective designs, homogeneous patient groups, and clonality assessment for accurate MRSA-MSSA virulence comparison.